Beam Therapeutics Inc. Shares Outstanding (Cover Page)
Beam Therapeutics Inc. (BEAM) had Shares Outstanding (Cover Page) of 103.29 million shares as of 2026-07-28, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-07-28: Entity Common Stock, Shares Outstanding 103.29M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 102.88M shares.
- 2026-02-17: Entity Common Stock, Shares Outstanding 101.86M shares.
- 2025-10-28: Entity Common Stock, Shares Outstanding 101.47M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-28 | 103.29M shares 10-Q · filed 2026-08-04 |
| 2026-04-30 | 102.88M shares 10-Q · filed 2026-05-07 |
| 2026-02-17 | 101.86M shares 10-K · filed 2026-02-24 |
| 2025-10-28 | 101.47M shares 10-Q · filed 2025-11-04 |
| 2025-07-29 | 101.16M shares 10-Q · filed 2025-08-05 |
| 2025-04-29 | 100.56M shares 10-Q · filed 2025-05-06 |
| 2025-02-18 | 83.69M shares 10-K · filed 2025-02-25 |
| 2024-10-29 | 82.81M shares 10-Q · filed 2024-11-05 |
| 2024-07-31 | 82.42M shares 10-Q · filed 2024-08-06 |
| 2024-04-30 | 82.31M shares 10-Q · filed 2024-05-07 |
| 2024-02-20 | 81.66M shares 10-K · filed 2024-02-27 |
| 2023-11-01 | 81.50M shares 10-Q · filed 2023-11-08 |
| 2023-08-01 | 79.20M shares 10-Q · filed 2023-08-08 |
| 2023-05-03 | 76.22M shares 10-Q · filed 2023-05-10 |
| 2023-02-22 | 72.40M shares 10-K · filed 2023-02-28 |
| 2022-10-31 | 70.47M shares 10-Q · filed 2022-11-07 |
| 2022-08-02 | 70.35M shares 10-Q · filed 2022-08-09 |
| 2022-05-02 | 70.27M shares 10-Q · filed 2022-05-09 |
| 2022-02-22 | 68.73M shares 10-K · filed 2022-02-28 |
| 2021-11-01 | 68.14M shares 10-Q · filed 2021-11-08 |
| 2021-08-03 | 66.35M shares 10-Q · filed 2021-08-10 |
| 2021-05-04 | 62.58M shares 10-Q · filed 2021-05-11 |
| 2021-03-08 | 62.42M shares 10-K · filed 2021-03-15 |
| 2020-11-06 | 57.97M shares 10-Q · filed 2020-11-10 |
| 2020-08-04 | 51.73M shares 10-Q · filed 2020-08-12 |
| 2020-05-08 | 51.49M shares 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |